Amy Conrad | Investor Relations |
Erik Holmlin | Chief Executive Officer |
Christopher Stewart | Chief Financial Officer |
Michael Okunewitch | Maxim Group |
Good day and welcome to the Bionano Genomics’ Second Quarter 2022 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Amy Conrad from Investor Relations. Please go ahead.
Thank you, Victor and good afternoon, everyone.